Research Institute of Molecular Pathology

The Research Institute of Molecular Pathology (IMP) is a biomedical research center, funded by the pharmaceutical company Boehringer Ingelheim, and by national and European research grants. The institute is located on the Campus Vienna Biocenter (VBC). The IMP employs around 250 people from 36 nations. The IMP's conducts research in the molecular life sciences. Research results are published in peer-reviewed journals.

Research Institute of Molecular Pathology

The Research Institute of Molecular Pathology (IMP) is a biomedical research center, funded by the pharmaceutical company Boehringer Ingelheim, and by national and European research grants. The institute is located on the Campus Vienna Biocenter (VBC). The IMP employs around 250 people from 36 nations. The IMP's conducts research in the molecular life sciences. Research results are published in peer-reviewed journals.